statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

ORIC Pharmaceuticals: Rally Seems Overdone

ORIC Pharmaceuticals: Rally Seems Overdone...

Oric Pharmaceuticals Bolsters Incentive Plan to Attract Talent

Oric Pharmaceuticals (ORIC) just unveiled an announcement. ORIC Pharmaceuticals has expanded its 2022 Inducement Equity Incentive Plan, adding 650...

Oric Pharmaceuticals (ORIC, $14.69) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 18, 2024

This is a Bearish indicator signaling ORIC's price could decline from here. Traders may explore shorting the stock or put options...

Oric Pharmaceuticals (ORIC, $14.69) entered Downtrend as Momentum indicator drops below 0 level on Mar 18, 2024

This indicator may be signaling that ORIC's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

The volume for Oric Pharmaceuticals stock increased for one day, resulting in a record-breaking daily growth of 276% of the 65-Day Volume Moving Average

ORIC's total volume now sits at 760.8K. The +0.73% price change was insignificant, leaving IBM's price at $15.1...

ORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial Results

Advances in Clinical Programs and Strengthened Cash Position HighlightedRelated Stocks: ORIC...

Oric Pharmaceuticals price target raised by $3 at Oppenheimer, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Oric Pharmaceuticals files automatic mixed securities shelf

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Volume	658,678.00
52-Wk High	$16.65
52-Wk Low	$5.27

ORIC ORIC Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals